Latest Bone Cancer News

  • January 3, 2008
    Oral bisphosphonates may lower jaw necrosis risk
    NEW YORK (Reuters Health) - A report in the Journal of the American Dental Association clarifies the risk of jaw osteonecrosis associated with bisphosphonates, which are used to prevent or slow the progression of osteoporosis.